After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity
Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…
#healthcare #publichealth #hospitaloperations #healthcarefinance
Saturday, February 28, 2026, 12:22 pm / permalink 19945 / 8 stories in 10 days
CMS freezes $260M in Medicaid funding to Minnesota, citing fraud concerns / Beckers
Jakob Emerson / beckershospitalreview - CMS is freezing $259.5 million in federal Medicaid funding to Minnesota, citing unsupported or potentially fraudulent claims in the state’s program. “We have decided to temporarily halt certain amounts of Medicaid funding that are going to the state of Mi…
#publichealth #cdc #wildlife #animalhealth #zoonoticdisease #avianinfluenza #infectiousdisease
Saturday, February 28, 2026, 5:22 am / permalink 19939 / 3 stories in 11 days
Microplastics discovered in prostate tumors / Medical Express
medicalxpress - Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center study was led by researchers at NYU Langone Health, its …
#healthcare #publichealth #oncology
Saturday, February 28, 2026, 12:23 am / permalink 19928 / 4 stories in 11 days
Boehringer wins accelerated approval for first-line use of lung cancer drug / Endpoints
Lei Lei Wu / endpoints - The FDA greenlit an expanded label for Boehringer Ingelheim’s lung cancer drug Hernexeos, marking the first use of the Commissioner's National Priority Voucher for a new indication. Boehringer won an accelerated
#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda #oncology
Saturday, February 28, 2026, 12:23 am / permalink 19927 / 9 stories in 11 days
Patient dies in MacroGenics' cancer study, FDA puts trial on hold / Endpoints
Max Gelman / endpoints - The FDA has placed a partial clinical hold on MacroGenics’ Phase 2 study in gynecologic cancers after one patient died and three others experienced life-threatening side effects, the company disclosed Tuesday. The patient who died ...
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #oncology
Saturday, February 28, 2026, 12:23 am / permalink 19925 / 3 stories in 11 days